Weeks 13 To 16 : 1.7 mg once weekly This is a higher step in the escalation process
If you're considering it, do it with a provider and use legitimately sourced medication
GLP-1 receptor agonist effects on lipid and liver profiles in patients with nonalcoholic fatty liver disease: systematic review and meta-analysis
Here are some of its competitors that are already FDA approved for weight management: Liraglutide (Saxenda) : This injectable medication is a once-daily GLP-1 receptor agonist approved for chronic weight management in adults with a body mass index (BMI) of 30 or greater (obesity) or 27 or greater (overweight) with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
The STEP 2 trial, which included individuals with type 2 diabetes, reported an average weight loss of approximately 9.6%
Ethical approval The animal experiments and procedures were performed in accordance with national guidelines for the use and care of laboratory animals, and the study was approved by Ataturk University's local animal care committee (approval number: 2014-1/12)
